BioNexus Gene Lab Corp - BGLC
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Chief Executive Officer | A | A | 338,709.0 | — | — | 338,709.0 | View | |
| Aug 14, 2026 | — | A | A | 32,258.0 | — | — | 32,258.0 | View | |
| Aug 14, 2026 | — | A | A | 32,258.0 | — | — | 32,258.0 | View | |
| Aug 14, 2026 | Chief Financial Officer | A | A | 96,774.0 | — | — | 96,774.0 | View | |
| Aug 14, 2026 | — | A | A | 16,129.0 | — | — | 17,390.0 | View |